Status:
COMPLETED
Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia
Lead Sponsor:
Mikkel Krogh-Madsen
Collaborating Sponsors:
Rigshospitalet, Denmark
Herlev Hospital
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
The present study is not hypothesis driven but will explore the ability of pharmacokinetic-pharmacodynamic modelling to predict optimal dosage of the chemotherapeutic drugs used in therapy in adult pa...
Eligibility Criteria
Inclusion
- adult men and women with newly diagnosed acute myeloid leukemia
Exclusion
- under age 18 years
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00969891
Start Date
September 1 2009
End Date
August 1 2011
Last Update
August 25 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Hematology clinic
Copenhagen, Denmark, 2100
2
Herlev Hospital, Hematology Clinic
Herlev, Denmark, 2730